Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice
D. H. Shin, H. Jiang, A. G. Gillard, D. K. Kim, X. Fan, S. K. Singh, T. T. Nguyen, S. S. Sohoni, A. R. Lopez-Rivas, A. Parthasarathy, C. I. Ene, J. Gumin, F. F. Lang, M. M. Alonso, C. Gomez-Manzano, J. Fueyo
This paper develops a chimeric oncolytic adenovirus that evades neutralizing antibodies and shows improved anti-glioma efficacy in mice.
bioRxiv · Jul 11, 2023Cancer Biology